Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants
NCT ID: NCT01571856
Last Updated: 2013-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
52 participants
INTERVENTIONAL
2011-07-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age
NCT04061538
Efficacy of Zinc Sulfate With Probiotics for the Treatment of Acute Diarrhea in Children
NCT01140074
Efficacy of Racecadotril in Acute Watery Diarrhea in Children
NCT01577043
Oral Zinc for the Treatment of Acute Diarrhea in US Children
NCT01198587
Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute
NCT02601742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: To evaluate the effect of zinc in the treatment of children under 6 months age with acute diarrhea.
Methods: A randomized clinical trial, controlled, double-blind. The investigators will have two groups of patients : One group will receive zinc plus oral rehydration and the other one will receive placebo plus oral rehydration; the parameters of evaluation are going to be the duration of diarrheal episode, number of diarrhea stools by day, weight of stool, nutritional state.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
zinc sulfate
zinc sulphate solution.
Zinc Sulfate
zinc sulfate solution, contains 20 mg. per 5 mL. dosage 2.5 mL. per day.
cornstarch solution
cornstarch powder diluted in distilled water
placebo
cornstarch powder diluted in distilled water, dosage 2.5 ml per day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zinc Sulfate
zinc sulfate solution, contains 20 mg. per 5 mL. dosage 2.5 mL. per day.
placebo
cornstarch powder diluted in distilled water, dosage 2.5 ml per day
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Severe dehydration
* Systemic infections
* coinfections
1 Month
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro Pediatrico Albina de Patino
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giuseppe Grandy
Medical Chief of Nutrition Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giuseppe Grandy, MD MSc
Role: STUDY_DIRECTOR
Centro Pediatrico Albina de Patino
Zaida Cama, MD
Role: STUDY_CHAIR
Centro Pediatrico Albina Ptino
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Pediatrico Albina Patino
Cochabamba, Departamento de Cochabamba, Bolivia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
protzinc2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.